Tradename | Proper name | Company | Number | Date | Products |
---|---|---|---|---|---|
Dupixent | dupilumab | Regeneron Pharmaceuticals | N-761055 RX | 2017-03-28 | 4 products |
Brand Name | Status | Last Update |
---|---|---|
dupixent | Biologic Licensing Application | 2024-09-27 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
atopic dermatitis | EFO_0000274 | D003876 | L20 |
Expiration | Code | ||
---|---|---|---|
dupilumab, Dupixent, Regeneron Pharmaceuticals, Inc. | |||
2029-05-20 | Orphan excl. |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Dermatitis | D003872 | — | L30.9 | 4 | 9 | 13 | 10 | 17 | 52 |
Atopic dermatitis | D003876 | EFO_0000274 | L20 | 4 | 9 | 12 | 10 | 17 | 51 |
Eczema | D004485 | — | L30.9 | 2 | 8 | 8 | 7 | 13 | 38 |
Asthma | D001249 | EFO_0000270 | J45 | 1 | 4 | 9 | 7 | 7 | 28 |
Rhinosinusitis | D000096825 | — | — | — | — | 6 | 3 | 3 | 12 |
Nasal polyps | D009298 | — | J33 | — | 1 | 4 | 3 | 3 | 11 |
Eosinophilic esophagitis | D057765 | EFO_0004232 | K20.0 | — | 2 | 3 | 3 | 2 | 9 |
Esophagitis | D004941 | HP_0100633 | K20 | — | 1 | 2 | 3 | 2 | 8 |
Sinusitis | D012852 | EFO_0007486 | J32 | — | 1 | 2 | 2 | 2 | 7 |
Polyps | D011127 | EFO_0000662 | — | — | — | 2 | 3 | — | 5 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neurodermatitis | D009450 | — | L28.0 | — | — | 5 | — | 2 | 7 |
Urticaria | D014581 | EFO_0005531 | L50 | — | 2 | 3 | — | — | 5 |
Prurigo | D011536 | — | L28.2 | — | — | 3 | — | 2 | 5 |
Chronic urticaria | D000080223 | — | L50.8 | — | 1 | 2 | — | — | 3 |
Hypersensitivity | D006967 | EFO_0003785 | T78.40 | — | 2 | 1 | — | — | 3 |
Allergic fungal sinusitis | D000092562 | — | — | — | — | 2 | — | — | 2 |
Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | — | — | 2 | — | — | 2 |
Lung diseases | D008171 | EFO_0003818 | J98.4 | — | — | 2 | — | — | 2 |
Obstructive lung diseases | D008173 | — | — | — | — | 2 | — | — | 2 |
Bullous pemphigoid | D010391 | EFO_0007187 | L12 | — | 1 | 1 | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Peanut hypersensitivity | D021183 | EFO_0007425 | — | — | 2 | — | — | — | 2 |
Aspergillosis | D001228 | EFO_0007157 | B44 | — | 1 | — | — | — | 1 |
Allergic bronchopulmonary aspergillosis | D001229 | EFO_0007140 | B44.81 | — | 1 | — | — | — | 1 |
Pulmonary aspergillosis | D055732 | EFO_1001834 | — | — | 1 | — | — | — | 1 |
Angioedema | D000799 | EFO_0005532 | T78.3 | — | 1 | — | — | — | 1 |
Allergic rhinitis | D065631 | — | J30.9 | — | 1 | — | — | — | 1 |
Rhinitis | D012220 | EFO_0008521 | J31 | — | 1 | — | — | — | 1 |
Alopecia areata | D000506 | EFO_0004192 | L63 | — | 1 | — | — | — | 1 |
Alopecia | D000505 | — | L64 | — | 1 | — | — | — | 1 |
Pulmonary eosinophilia | D011657 | EFO_0007257 | J82.81 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 7 | — | — | — | — | 7 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Conjunctivitis | D003231 | — | H10 | — | — | — | — | 2 | 2 |
Colorectal neoplasms | D015179 | — | — | — | — | — | — | 2 | 2 |
Nasopharyngeal neoplasms | D009303 | — | — | — | — | — | — | 2 | 2 |
Pathologic processes | D010335 | — | — | — | — | — | — | 1 | 1 |
Anosmia | D000086582 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Dupilumab |
INN | dupilumab |
Description | Dupilumab (human mab) |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | >6WG8:A|Dupilumab Fab heavy chain
EVQLVESGGGLEQPGGSLRLSCAGSGFTFRDYAMTWVRQAPGKGLEWVSSISGSGGNTYYADSVKGRFTISRDNSKNTLY
LQMNSLRAEDTAVYYCAKDRLSITIRPRYYGLDVWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPE
PVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGHHHHHH
>6WG8:B|Dupilumab Fab light chain
DIVMTQSPLSLPVTPGEPASISCRSSQSLLYSIGYNYLDWYLQKSGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKI
SRVEAEDVGFYYCMQALQTPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQ
SGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTQGTTSVTKSFNRGEC |
PDB | 6WG8, 6WGB, 6WGJ, 6WGK, 6WGL |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2108675 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB12159 |
UNII ID | 420K487FSG (ChemIDplus, GSRS) |